Form 6-K China Nepstar Chain Drug For: Mar 29
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/30/2026
- S&P 500 flat as higher bond yields counter tech optimism
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
- Risk appetite remains concentrated in large-cap stocks, Citi says
- Netflix stock: Deutsche Bank gets bullish as valuation leaves room to run
- CarMax shares rise over 2% on strong earnings and revenue beat
- Salesforce agrees to acquire AI research platform Listen Labs
- Workday cuts 2.5% of workforce, revises GAAP margin outlook
- S&P 500 flat as higher bond yields counter tech optimism
- Wells Fargo raises oil price targets citing ongoing supply risks
- Anthropic prospectus shows $2T IPO ambition, warns of AI 'existential risk'
China Nepstar Chain Drugstore (NPD) Reports Q4 EPS of RMB0.38
March 29, 2016 6:24 AM EDTChina Nepstar Chain Drugstore (NYSE: NPD) reported Q4 EPS of RMB0.38, versus RMB0.34 reported last year. Revenue for the quarter came in at RMB905.2 million, versus RMB850.1 million reported last year.
Same store sales increased by 12.5% compared to the fourth quarter of... More
